Naarden Jacob Van's Net Worth
$29.8 Million
Who is Naarden Jacob Van?
Naarden Jacob Van has an estimated net worth of $29.8 Million. This is based on reported shares across multiple companies, which include ELI LILLY & Co, and Loxo Oncology, Inc..
SEC CIK
Naarden Jacob Van's CIK is 0001661254
Past Insider Trading and Trends
2018 was Naarden Jacob Van's most active year for acquiring shares with 29 total transactions. Naarden Jacob Van's most active month to acquire stocks was the month of January. 2018 was Naarden Jacob Van's most active year for disposing of shares, totalling 137 transactions. Naarden Jacob Van's most active month to dispose stocks was the month of October. 2024 saw Naarden Jacob Van paying a total of $1,746,568.94 for 9,010 shares, this is the most they've acquired in one year. In 2019 Naarden Jacob Van cashed out on 541,969 shares for a total of $127,362,715.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ELI LILLY & Co (LLY) Snapshot price: $900.9999
EVP & Pres., Lilly Oncology
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -26.64% | -4.30K |
—
|
—
| 11.85K |
Oct 31
| |||
Form 4
| +17.19% | 2.37K |
$737.26 | $1,746,568.94 | 16.15K |
Feb 12
| |||
Form 4
| +16.32% | 1.93K |
$645.61 | -$1,087,852.85 | 13.78K |
Feb 1
| |||
Form 4
| +14.18% | 1.47K |
$335.01 | -$440,203.14 | 11.85K |
Feb 16
| |||
Form 4
| +30.21% | 2.41K |
$345.12 | $830,703.84 | 10.37K |
Feb 10
| |||
Form 4
| +69.80% | 3.27K |
$243.84 | -$533,034.24 | 7.97K |
Feb 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Loxo Oncology, Inc. No price found
Chief Operating Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -19.00K |
$235.00 | -$4,465,000.00 |
0
|
Feb 15
| |||
Form 4/A
| +12.84% | 1.54K |
$3.65 | $5,621.57 | 13.54K |
Scheduled
|
Jul 9
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
| +51.09% | 7K |
$72.40 | -$1,070,947.87 | 20.7K |
Scheduled
|
Dec 10 - Dec 11
| ||
Form 4
|
—
|
0
|
$76.84 | -$1,422,610.28 | 13.7K |
Scheduled
|
Nov 26 - Nov 27
| ||
Form 4
|
—
|
0
|
$84.39 | -$1,614,781.34 | 13.7K |
Scheduled
|
Oct 4 - Oct 4
| ||
Form 4
|
—
|
0
|
$84.99 | -$1,626,698.89 | 13.7K |
Scheduled
|
Sep 12 - Sep 13
| ||
Form 4
|
—
|
0
|
$81.50 | -$1,556,966.48 | 13.7K |
Scheduled
|
Aug 13 - Aug 14
| ||
Form 4
|
—
|
0
|
$93.58 | -$554,295.08 | 13.7K |
Scheduled
|
Jul 9 - Jul 10
| ||
Form 4
|
∞
| 12K |
$90.90 | -$494,016.92 | 12K |
Scheduled
|
Jun 19 - Jun 20
| ||
Form 4
|
—
|
0
|
$70.54 | -$412,271.59 |
0
|
Scheduled
|
May 14 - May 15
| ||
Form 4
|
—
|
0
|
$67.44 | -$393,217.44 |
0
|
Scheduled
|
Apr 24 - Apr 25
| ||
Form 4
|
—
|
0
|
$67.53 | -$393,751.83 |
0
|
Scheduled
|
Mar 13 - Mar 14
| ||
Form 4
|
—
|
0
|
$50.00 | -$285,668.84 |
0
|
Scheduled
|
Feb 12 - Feb 13
| ||
Form 4
|
—
|
0
|
$45.93 | -$260,623.32 |
0
|
Scheduled
|
Jan 16 - Jan 17
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
—
|
0
|
$42.42 | -$238,997.18 |
0
|
Scheduled
|
Dec 14 - Dec 15
| ||
Form 4
|
—
|
0
|
$39.08 | -$218,354.78 |
0
|
Scheduled
|
Nov 27 - Nov 28
| ||
Form 4
|
—
|
0
|
$45.27 | -$256,545.76 |
0
|
Scheduled
|
Oct 30 - Oct 31
| ||
Form 4
|
—
|
0
|
$46.33 | -$263,045.97 |
0
|
Scheduled
|
Sep 18 - Sep 19
| ||
Form 4
|
—
|
0
|
$38.61 | -$215,509.64 |
0
|
Scheduled
|
Aug 14 - Aug 15
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |